,i  #aae? ,,congress  #b;d ,session  ,h4
 ,r4 #eibf  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,may #bc1 #bjah,mr4   
,keat+ 7= himself & ,mr4 ,ro?fus7       
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce  ,a  
,,bill  ,to require ! ,secret>y ( ,heal?
 & ,human ,s]vices to issue guidel9es = 
prescrib+ naloxone1 & = o!r purposes4   
#a4 ,%ort title ,?is ,act may be cit$ z 
! ,naloxone ,guidel9es ,act ( #bjah4    
#b4 ,guidel9es = prescrib+ naloxone  7a7
 ,9 g5]al ,n lat] ?an #ahj days aft] !  
date ( ! enactm5t ( ?is ,act1 !         
,secret>y ( ,heal? & ,human ,s]vices    
%all issue guidel9es = prescrib+ an     
opioid ov]dose rev]sal drug4  7b7       
,cont5ts ,9 issu+ guidel9es "u          
subsection 7a71 ! ,secret>y %all address
 ! foll[+3 7#a7 ,co-prescrib+ an opioid 
ov]dose rev]sal drug 9 conjunction ) any
 prescrib$ opioid4  7#b7 ,dosage safety4
  7#c7 ,prescrib+ an opioid ov]dose     
rev]sal drug to an individual o!r ?an a 
pati5t4  7#d7 ,/&+ ord]s4  7#e7 ,o!r    

di/ribution1 education1 & safety        
measures z det]m9$ necess>y4